NEW! Editorial Deep Dive // Can Biologicals Deliver Consistency, Credibility, and Scale?
Go beyond the main-stage R&D conversations and focus on real-world commercialization and deployment. As the main stage pauses, these fast-paced panels and interactive roundtables in breakout rooms will explore what it takes to bring AI-powered robotics and autonomous machinery to market across both broadacre and specialty crop systems. Hear practical insights from corporates, startups, and investors, and join the conversation to surface new ideas, share challenges, and co-create solutions that can scale.
- With oversupply, pricing pressure, and generics flooding the market, how can companies across the biologicals value chain deliver differentiated, trusted solutions to growers?
- From bioprotection to biostimulants, which categories and new solutions show the most promise in the context of strained farm economics, and how can we improve consistency in biological efficacy to move beyond one-season successes towards long-term agronomic value?
- How can the industry establish higher standards and seamless data flow, and what role should regulators play in enabling faster, science-based registration of biological products?
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)